Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950170-24-114476
Filing Date
2024-10-15
Accepted
2024-10-15 08:51:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 425 aktx_425_10.15.2024.htm 425 26095
  Complete submission text file 0000950170-24-114476.txt   28110
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Filed by) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: 425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Subject) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: 425 | Act: 34 | File No.: 001-36288 | Film No.: 241369550
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)